For Family and Friends
Safety Information
 

Caregiver CLL Resources

If someone you love has chronic lymphocytic leukemia (CLL), there are organizations and support groups for you. They can help you connect with others. They can also help you learn all you can about CLL. Below are some resources for caregivers.

The Leukemia & Lymphoma Society (LLS): For Caregivers

American Cancer Society (ACS)

  • Visit this page for a list of links for caregivers within the ACS website. It also includes a caregiver discussion board. Go to ACS Caregiver’s page

National Cancer Institute

  • Visit the NCI’s caregiver’s section. It includes information to help you care for your loved one and yourself. Go to NCI Caregiver’s page
 
 

Get more resources and support

See the full list of CLL Resources.


Go Now

Genentech and Biogen Idec are not affiliated with any of the organizations on this page. The information provided by Genentech, Biogen Idec, or these organizations is meant for informational purposes only and is not meant to replace your physician’s medical advice.

Next Section Caring for Yourself

Indications

RITUXAN® (Rituximab) is indicated in combination with fludarabine and cyclophosphamide (FC chemotherapy) for the treatment of patients with:

  • Previously untreated CD20-positive CLL
  • Previously treated CD20-positive CLL

People with serious infections should not receive RITUXAN.

Safety Information

  • RITUXAN can cause serious side effects that can lead to death, including: infusion reactions, tumor lysis syndrome (TLS; kidney failure due to fast breakdown of cancer cells), severe skin and mouth reactions, and progressive multifocal leukoencephalopathy (PML; a rare, serious brain infection).
  • RITUXAN has also been associated with serious and life-threatening side effects, including: the return of active hepatitis B virus infection with sudden and serious liver problems including liver failure, and death, other serious infections that can lead to death, heart problems, kidney problems, and stomach and serious bowel problems including blockage and tears in the bowel that can sometimes lead to death.
  • The most common side effects of RITUXAN seen in clinical trials of patients with CLL were infusion reactions and low white blood cells, which can increase the risk of infections. Before starting treatment with RITUXAN it is important for you to talk to your doctor about your medical history.
  • Tell your doctor about any side effect that bothers you or that does not go away. These are not all of the possible side effects with RITUXAN. For more information, ask your doctor.

Please see full Prescribing Information, including Medication Guide, in PDF format.